Woodford
Woodford Equity Income investors set for third payment amid fire sale
Majority of assets now sold
Juno Capital declares reports of Woodford employment 'untrue'
Relationship is 'preliminary due diligence'
Woodford appointed advisor to fund manager Juno Capital
Working on portfolio of unquoted healthcare investments
Woodford investors take Covid-19 hit as Link agrees £224m sale of healthcare assets
Link Fund Solutions (LFS) has agreed to sell "a significant portion" of the stricken LF Equity Income fund's holdings to US firm Acacia Research Corporation for up to £223.9m.
Law firm considers compensation claims against Link over Woodford collapse
Legal claims for compensation are being considered against the Woodford Equity Income fund's (WEIF) authorised corporate director (ACD) Link Fund Solutions, which is accused of early-stage failures in the fund's collapse, a failure to act in the best...
Hargreaves Lansdown to scrap Wealth 50 List - reports
16 months after its launch
Woodford investors to receive second payment on 25 March
Additional £141.7m sold
Mark Barnett's income portfolios hit with further outflows - reports
Concerns on liquidity and performance
ASI reveals details of Woodford fund overhaul
LF ASI Income Focus due to reopen on Thursday
Liontrust's Geffen slides out of Sanlam Income Study's White List
Liontrust Income falls 19 places into grey list
Move over Bailey: What advisers want from the new FCA head
Advisers want a more responsive regulator
Woodford ACD Link: We acted in investors' best interests
Group dismisses claims it failed in its role over Woodford fund
Woodford Income Focus suspended
Elevated redemptions expected
Update: Woodford Patient Capital suffers fresh NAV writedown
Three company valuations reduced
Woodford offloads IP Group in cut-price £76m deal - reports
Sells entire 13.5% stake
Andrew Aldridge: There should be no grey areas in illiquid investments
'Lack of understanding'
Woodford holding Benevolent AI sees valuation halve
'Holding halved'
Woodford Patient Capital suffers NAV writedown
Unnamed company valuation reduced
Woodford Patient Capital booted out of FTSE 250
One of six relegations
Woodford buys unloved FTSE 100 trio
Repositioning portfolio
